CTI BioPharma
CTIC
#5622
Rank
โ‚ฌ1.02 B
Marketcap
7,81ย โ‚ฌ
Share price
0.00%
Change (1 day)
18.92%
Change (1 year)

CTI BioPharma (CTIC) - Total liabilities

Total liabilities on the balance sheet as of March 2023 : โ‚ฌ0.11 Billion

According to CTI BioPharma 's latest financial reports the company's total liabilities are โ‚ฌ0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CTI BioPharma - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ0.13 B120.64%
2021-12-31โ‚ฌ60.63 M309.5%
2020-12-31โ‚ฌ14.8 M-41.49%
2019-12-31โ‚ฌ25.3 M-21.53%
2018-12-31โ‚ฌ32.24 M-0.26%
2017-12-31โ‚ฌ32.33 M-39.36%
2016-12-31โ‚ฌ53.32 M-39.85%
2015-12-31โ‚ฌ88.64 M100.35%
2014-12-31โ‚ฌ44.24 M19.89%
2013-12-31โ‚ฌ36.9 M19.74%
2012-12-31โ‚ฌ30.82 M16.93%
2011-12-31โ‚ฌ26.35 M-40.31%
2010-12-31โ‚ฌ44.15 M-28.4%
2009-12-31โ‚ฌ61.67 M-54.11%
2008-12-31โ‚ฌ0.13 B8.18%
2007-12-31โ‚ฌ0.12 B-19.41%
2006-12-31โ‚ฌ0.15 B-30.44%
2005-12-31โ‚ฌ0.22 B17.57%
2004-12-31โ‚ฌ0.18 B3.8%
2003-12-31โ‚ฌ0.18 B32.48%
2002-12-31โ‚ฌ0.13 B-37.66%
2001-12-31โ‚ฌ0.21 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
โ‚ฌ69.16 B 58,410.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ67.24 B 56,788.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚ฌ1.44 B 1,120.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ11.89 B 9,966.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ78.23 B 66,086.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.00 B 23,590.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
โ‚ฌ53.71 B 45,342.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland